The ischemic preconditioning effect of adenosine in patients with ischemic heart disease

作者: Bita Sadigh , Miguel Quintana , Christer Sylvén , Margareta Berglund , Lars Åke Brodin

DOI: 10.1186/1476-7120-7-52

关键词:

摘要: In vivo and in vitro evidence suggests that adenosine its agonists play key roles the process of ischemic preconditioning. The effects low-dose infusion on preconditioning have not been thoroughly studied humans. We hypothesised a could reduce burden evoked by physical exercise improve regional left ventricular (LV) systolic function. nine severely symptomatic male patients with severe coronary artery disease. Myocardial ischemia was induced two separate occasions quantified Tissue Doppler Echocardiography. Prior to test, intravenous or placebo infused over ten minutes according randomized, double blind, cross-over protocol. LV walls were defined as if reduction, no increment, an increment < 15% peak velocity (PSV) observed during maximal compared baseline values prior placebo-infusion. Otherwise, non-ischemic. PSV increased from non-ischemic both (P = 0.0001) 0.0009). However, walls, only 0.001), while changes occurred NS). Low-dose reduced improved function exercise-induced myocardial ischemia, confirming is potential agent

参考文章(21)
Miguel Quintana, , Paul Hjemdahl, Alf Sollevi, Thomas Kahan, Magnus Edner, Nina Rehnqvist, Eva Swahn, Ann-Catrin Kjerr, Per Näsman, Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis. European Journal of Clinical Pharmacology. ,vol. 59, pp. 1- 9 ,(2003) , 10.1007/S00228-003-0564-8
Shereif H Rezkalla, Robert A Kloner, Ischemic preconditioning and preinfarction angina in the clinical arena. Nature Reviews Cardiology. ,vol. 1, pp. 96- 102 ,(2004) , 10.1038/NCPCARDIO0047
Robert M Mentzer Jr, Vladimir Birjiniuk, Shukri Khuri, James E Lowe, Peter S Rahko, Richard D Weisel, Harry A Wellons, Matthew L Barker, Robert D Lasley, Adenosine Myocardial Protection Investigators, Adenosine myocardial protection: preliminary results of a phase II clinical trial. Annals of Surgery. ,vol. 229, pp. 643- 650 ,(1999) , 10.1097/00000658-199905000-00006
D.M Yellon, A.M Alkhulaifi, W.B Pugsley, Preconditioning the human myocardium The Lancet. ,vol. 342, pp. 276- 277 ,(1993) , 10.1016/0140-6736(93)91819-8
Peter Cain, Terri Baglin, Colin Case, Danielle Spicer, Leanne Short, Thomas H Marwick, Application of tissue Doppler to interpretation of Dobutamine echocardiography and comparison with quantitative coronary angiography American Journal of Cardiology. ,vol. 87, pp. 525- 531 ,(2001) , 10.1016/S0002-9149(00)01425-9
Yoshio Doi, Go Watanabe, Keiju Kotoh, Katsushi Ueyama, Takuro Misaki, Myocardial ischemic preconditioning during minimally invasive direct coronary artery bypass grafting attenuates ischemia-induced electrophysiological changes in human ventricle. The Japanese Journal of Thoracic and Cardiovascular Surgery. ,vol. 51, pp. 144- 150 ,(2003) , 10.1007/S11748-003-0050-3
P. Blardi, F. Laghi Pasini, R. Urso, C. Frigerio, L. Volpi, L. De Giorgi, T. Di Perri, Pharmacokinetics of exogenous adenosine in man after infusion European Journal of Clinical Pharmacology. ,vol. 44, pp. 505- 507 ,(1993) , 10.1007/BF00315554
Christer Sylvén, Björn Eriksson, Jens Jensen, Evy Geigant, Rolf G. Hallin, Analgesic effects of adenosine during exercise-provoked myocardial ischaemia Neuroreport. ,vol. 7, pp. 1521- 1525 ,(1996) , 10.1097/00001756-199606170-00017
MICHAEL S. MARBER, DEREK M. YELLON, Myocardial adaptation, stress proteins, and the second window of protection. Annals of the New York Academy of Sciences. ,vol. 793, pp. 123- 141 ,(1996) , 10.1111/J.1749-6632.1996.TB33510.X